2025-03-09 - Analysis Report
## Eli Lilly and Co (LLY) Stock Analysis Report

This report analyzes Eli Lilly and Co (LLY), a leading pharmaceutical company, based on the provided data.

**1) Performance Comparison and Divergence:**

LLY's cumulative return (629.29%) significantly outperforms the S&P 500 (VOO) cumulative return (108.62%).  The difference is 520.7%, placing it at the 82.7th percentile of the historical divergence range (max: 634.5, min: -25.2). This indicates LLY's substantial outperformance relative to the broader market over the analyzed period.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 9.0% | 4.3% | -19.0% | 0.0 | 67.7 |
| 2016-2018  | 47.0% | 4.3% | 29.0% | 0.0 | 95.1 |
| 2017-2019  | 60.0% | 8.8% | 29.0% | 1.0 | 110.5 |
| 2018-2020  | 90.0% | 11.2% | 62.0% | 0.3 | 144.7 |
| 2019-2021  | 145.0% | 11.2% | 74.0% | 0.2 | 240.4 |
| 2020-2022  | 196.0% | 11.2% | 187.0% | 0.2 | 322.7 |
| 2021-2023  | 300.0% | 10.8% | 277.0% | 0.3 | 519.3 |
| 2022-2024  | 396.0% | 11.1% | 363.0% | 0.3 | 692.2 |
| 2023-2025  | 386.0% | 11.1% | 336.0% | 0.3 | 781.0 |


The data shows a consistently high CAGR (Compound Annual Growth Rate) and increasing market capitalization (Cap(B)) over the years.  Alpha is mostly positive, indicating outperformance relative to the benchmark,  while Beta fluctuates, suggesting varying sensitivity to market movements.  Maximum Drawdown (MDD) is relatively low considering the high returns.

**2) Recent Price Movement:**

* **Closing Price:** $869.58
* **Previous Close:** $912.76
* **Change:** -$4.73 (a -0.52% decrease)
* **5-Day Moving Average:** $910.57
* **20-Day Moving Average:** $887.08
* **60-Day Moving Average:** $818.80

The price is below all three moving averages, suggesting a potential short-term downward trend.  The recent significant price drop (-$4.73) warrants further investigation into the underlying cause.

**3) Technical Indicators and Expected Return:**

* **RSI:** 56.25 (Slightly above the neutral level of 50, indicating neither overbought nor oversold conditions)
* **PPO:** -0.36 (Negative value suggests bearish momentum)
* **20-Day Relative Divergence Change:** -6.2% (Short-term downward trend)
* **Expected Return (2+ years):** 95.6% (significantly higher than S&P 500)


The negative price change and PPO value suggest a bearish short-term trend, despite the positive long-term outlook indicated by the high expected return.  The significant price drop needs further investigation.

**4) Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|--------------|
| 2024-10-30 | $1.08 | $11.44 B     |
| 2024-08-08 | $3.29 | $11.30 B     |
| 2024-04-30 | $2.49 | $8.77 B      |
| 2023-11-02 | -$0.06| $9.50 B      |
| 2024-10-30 | -$0.06| $9.50 B      |

There appears to be a duplication of the 2024-10-30 entry.  Excluding the duplicate, revenue is generally stable, but EPS shows significant variability, indicating potential volatility in profitability.  Further investigation into the reasons for fluctuating EPS is necessary.

**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|------------|---------------|
| 2024-12-31 | $13.53B   | 82.24%        |
| 2024-09-30 | $11.44B   | 81.02%        |
| 2024-06-30 | $11.30B   | 80.80%        |
| 2024-03-31 | $8.77B    | 80.91%        |
| 2023-12-31 | $9.35B    | 80.88%        |

Revenue shows a clear upward trend in recent quarters. Profit margins are consistently high, demonstrating strong profitability.


**Capital and Profitability:**

| Quarter | Equity     | ROE           |
|---------|------------|---------------|
| 2024-12-31 | $14.19B   | 31.07%        |
| 2024-09-30 | $14.24B   | 6.81%         |
| 2024-06-30 | $13.56B   | 21.88%        |
| 2024-03-31 | $12.81B   | 17.51%        |
| 2023-12-31 | $10.77B   | 20.33%        |

Equity shows an increasing trend, and while ROE fluctuates, it generally remains strong, indicating efficient use of capital.


**6) Overall Conclusion:**

LLY exhibits strong long-term performance significantly outpacing the S&P 500.  High CAGR, positive alpha, and consistently high profit margins point to a robust and profitable company. However, recent price action shows a short-term decline, and EPS volatility requires further analysis. The high expected return makes it potentially attractive for long-term investors, but the recent price drop and bearish technical indicators warrant cautious monitoring.  Further investigation into the causes of the recent price drop and fluctuating EPS is crucial before making any investment decisions.
